bupropion has been researched along with Phobic Disorders in 5 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 12-week, open label flexible dosing study was conducted to evaluate the efficacy of bupropion-SR in the treatment of generalized social phobia." | 2.69 | Bupropion-SR in treatment of social phobia. ( Ballenger, JC; Book, SW; Brawman-Mintzer, O; Emmanuel, NP; Johnson, MR; Lorberbaum, JP; Lydiard, RB; Morton, WA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheehan, DV | 2 |
| Davidson, J | 1 |
| Manschreck, T | 1 |
| Van Wyck Fleet, J | 1 |
| Emmanuel, NP | 2 |
| Brawman-Mintzer, O | 1 |
| Morton, WA | 1 |
| Book, SW | 1 |
| Johnson, MR | 1 |
| Lorberbaum, JP | 1 |
| Ballenger, JC | 2 |
| Lydiard, RB | 2 |
1 trial available for bupropion and Phobic Disorders
| Article | Year |
|---|---|
Bupropion-SR in treatment of social phobia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Female; Hum | 2000 |
4 other studies available for bupropion and Phobic Disorders
| Article | Year |
|---|---|
Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.
Topics: Adult; Antidepressive Agents; Bupropion; Fear; Female; Humans; Male; Middle Aged; Panic; Phobic Diso | 1983 |
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear; | 1984 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; C | 1994 |
Treatment of social phobia with bupropion.
Topics: Adult; Antidepressive Agents; Anxiety; Bupropion; Female; Humans; Phobic Disorders; Social Behavior | 1991 |